Home Healthcare Healthcare Services Neurology Clinical Trials Market

Neurology Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
  7. North America Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  8. Europe Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  9. APAC Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  10. Middle East and Africa Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  11. LATAM Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  12. Competitive Landscape
    1. Neurology Clinical Trials Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. IQVIA
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Novartis
    3. Covance
    4. Medpace
    5. Charles River Laboratories
    6. SyneousHealth
    7. Icon Plc
    8. GlaxoSmithKline
    9. Aurora healthcare
    10. Biogen
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer

List of Tables

Table 1: Global Neurology Clinical Trials Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 3: Global Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 4: Global Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 5: North America Neurology Clinical Trials Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 6: North America Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 7: North America Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 8: North America Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 9: U.S. Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 10: U.S. Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 11: U.S. Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 12: Canada Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 13: Canada Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 14: Canada Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 15: Europe Neurology Clinical Trials Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 16: Europe Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 17: Europe Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 18: Europe Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 19: U.K. Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 20: U.K. Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 21: U.K. Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 22: Germany Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 23: Germany Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 24: Germany Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 25: France Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 26: France Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 27: France Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 28: Spain Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 29: Spain Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 30: Spain Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 31: Italy Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 32: Italy Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 33: Italy Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 34: Russia Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 35: Russia Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 36: Russia Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 37: Nordic Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 38: Nordic Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 39: Nordic Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 40: Benelux Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 41: Benelux Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 42: Benelux Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 43: Rest of Europe Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 44: Rest of Europe Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 45: Rest of Europe Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 46: APAC Neurology Clinical Trials Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 47: APAC Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 48: APAC Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 49: APAC Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 50: China Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 51: China Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 52: China Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 53: Korea Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 54: Korea Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 55: Korea Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 56: Japan Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 57: Japan Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 58: Japan Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 59: India Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 60: India Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 61: India Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 62: Australia Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 63: Australia Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 64: Australia Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 65: Taiwan Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 66: Taiwan Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 67: Taiwan Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 68: South East Asia Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 69: South East Asia Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 70: South East Asia Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 71: Rest of Asia-Pacific Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 72: Rest of Asia-Pacific Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 73: Rest of Asia-Pacific Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 74: Middle East and Africa Neurology Clinical Trials Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 75: Middle East and Africa Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 76: Middle East and Africa Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 77: Middle East and Africa Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 78: UAE Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 79: UAE Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 80: UAE Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 81: Turkey Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 82: Turkey Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 83: Turkey Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 84: Saudi Arabia Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 85: Saudi Arabia Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 86: Saudi Arabia Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 87: South Africa Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 88: South Africa Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 89: South Africa Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 90: Egypt Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 91: Egypt Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 92: Egypt Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 93: Nigeria Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 94: Nigeria Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 95: Nigeria Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 96: Rest of MEA Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 97: Rest of MEA Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 98: Rest of MEA Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 99: LATAM Neurology Clinical Trials Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 100: LATAM Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 101: LATAM Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 102: LATAM Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 103: Brazil Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 104: Brazil Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 105: Brazil Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 106: Mexico Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 107: Mexico Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 108: Mexico Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 109: Argentina Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 110: Argentina Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 111: Argentina Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 112: Chile Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 113: Chile Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 114: Chile Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 115: Colombia Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 116: Colombia Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 117: Colombia Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 118: Rest of LATAM Neurology Clinical Trials Market Size and Forecast By Phase - 2022-2034 (USD Billion)

Table 119: Rest of LATAM Neurology Clinical Trials Market Size and Forecast By Study Design - 2022-2034 (USD Billion)

Table 120: Rest of LATAM Neurology Clinical Trials Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.